The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)

To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. The Diabetes Incidence Study in Sweden (DISS) aims to register all incident cases of diabetes aged 15-34 years in Sw...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2003-02, Vol.26 (2), p.349-354
Hauptverfasser: HENRICSSON, Marianne, NYSTRÖM, Lennarth, ERIKSSON, Jan W, SUNDKVIST, Göran, BLOHME, Göran, ÖSTMAN, Jan, KULLBERG, Carin, SVENSSON, Maria, SCHÖLIN, Anna, ARNQVIST, Hans J, BJÖRK, Elisabeth, BOUNDER, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 354
container_issue 2
container_start_page 349
container_title Diabetes care
container_volume 26
creator HENRICSSON, Marianne
NYSTRÖM, Lennarth
ERIKSSON, Jan W
SUNDKVIST, Göran
BLOHME, Göran
ÖSTMAN, Jan
KULLBERG, Carin
SVENSSON, Maria
SCHÖLIN, Anna
ARNQVIST, Hans J
BJÖRK, Elisabeth
BOUNDER, Jan
description To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. The Diabetes Incidence Study in Sweden (DISS) aims to register all incident cases of diabetes aged 15-34 years in Sweden. In 1987-1988, 806 cases were reported, and 627 (78%) of them were followed up with regard to retinopathy 8-10 years later. The assessment was based on retinal photographs in most cases (86%). Ten years after diagnosis, retinopathy was found in 247 patients (39%). The retinopathy was mild in 206 (33%), whereas 30 (4.8%) patients had moderate nonproliferative DR (NPDR) and 11 (1.8%) had proliferative DR (PDR). Patients with retinopathy had worse glycemic control during the years than patients without (HbA(1c) 8.1 +/- 1.5% and 6.8 +/- 1.2%, respectively; P < 0.001). In a Cox regression analysis, time to retinopathy was related to high HbA(1c) (P < 0.001) and high BMI (P = 0.001). Patients with type 2 diabetes had an increased prevalence of severe retinopathy (NPDR or PDR) compared with those with type 1 diabetes (14 of 93 [15%] versus no or mild 24 of 471 [5%], respectively; P < 0.001). Despite modern diabetes management, 39% of young adult diabetic patients developed retinopathy within the first 10 years of the disease. Nevertheless, compared with the prevalence of retinopathy (63%), after a similar duration of diabetes before the Diabetes Control and Complications Trial, this prevalence was clearly lower. Current treatment aimed to achieve strict glycemic control has reduced the risk for developing retinopathy.
doi_str_mv 10.2337/diacare.26.2.349
format Article
fullrecord <record><control><sourceid>gale_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_591189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A98032947</galeid><sourcerecordid>A98032947</sourcerecordid><originalsourceid>FETCH-LOGICAL-g568t-778658f7533b4ca64da2bf5cc0c2f70b512ca0e16e27190d2a9ad6709e87cfda3</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdRbK3eeyVBUBScNckkk8llaf0oFLzY6m04kznZps5OpskMy_4rf6Kp3booFiSEJCfPe95zSIriOaMLXlXqfefBQsQFrxd8UQn9oDhkupKllKJ5WBxSJnQpteYHxZOUriilQjTN4-KAcSlUU7PD4sfFJZKzwfoOB4skOBJx8kMYYbrcEkbJFiEmAm7CSLLdagjJJ-IHsg3zsCLQzf1ERgxjj2Tjp0ty6qHFCVNOlPJdIi6GNZmyzQCTD8MmW5ExjHP_61i2kLDbq_a1LKe52944LTeYI-TN6dly-fZp8chBn_DZbj0qvn78cHHyuTz_8uns5Pi8XMm6mUqV25ONU7KqWmGhFh3w1klrqeVO0VYyboEiq5ErpmnHQUNXK6qxUdZ1UB0V5W3etMFxbs0Y_Rri1gTwZhf6nndopGas0ZlX9_JjDN1edCdkWgrBaVae36vs5zHPNs8bBVLtai2ckciUEYyBaRw0ptW6zkWIjkmb0727N92p_3ZsQlyZeTacsYpW_4f3PvNCU57x17d47ul6xjSZtU8W-x4GDHMyimsllZAZfPkXeBXmOOQnM5xTVgvO1d58BT0aP7gwRbArHDBCHwZ0PoePdUMrroXav8kfeB4drr39F_9iV8PcrrH73dvd98_Aqx0AyULvIuTfl_Zc7qOuWV39BFErGDQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220164227</pqid></control><display><type>article</type><title>The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)</title><source>MEDLINE</source><source>SWEPUB Freely available online</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>HENRICSSON, Marianne ; NYSTRÖM, Lennarth ; ERIKSSON, Jan W ; SUNDKVIST, Göran ; BLOHME, Göran ; ÖSTMAN, Jan ; KULLBERG, Carin ; SVENSSON, Maria ; SCHÖLIN, Anna ; ARNQVIST, Hans J ; BJÖRK, Elisabeth ; BOUNDER, Jan</creator><creatorcontrib>HENRICSSON, Marianne ; NYSTRÖM, Lennarth ; ERIKSSON, Jan W ; SUNDKVIST, Göran ; BLOHME, Göran ; ÖSTMAN, Jan ; KULLBERG, Carin ; SVENSSON, Maria ; SCHÖLIN, Anna ; ARNQVIST, Hans J ; BJÖRK, Elisabeth ; BOUNDER, Jan</creatorcontrib><description>To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. The Diabetes Incidence Study in Sweden (DISS) aims to register all incident cases of diabetes aged 15-34 years in Sweden. In 1987-1988, 806 cases were reported, and 627 (78%) of them were followed up with regard to retinopathy 8-10 years later. The assessment was based on retinal photographs in most cases (86%). Ten years after diagnosis, retinopathy was found in 247 patients (39%). The retinopathy was mild in 206 (33%), whereas 30 (4.8%) patients had moderate nonproliferative DR (NPDR) and 11 (1.8%) had proliferative DR (PDR). Patients with retinopathy had worse glycemic control during the years than patients without (HbA(1c) 8.1 +/- 1.5% and 6.8 +/- 1.2%, respectively; P &lt; 0.001). In a Cox regression analysis, time to retinopathy was related to high HbA(1c) (P &lt; 0.001) and high BMI (P = 0.001). Patients with type 2 diabetes had an increased prevalence of severe retinopathy (NPDR or PDR) compared with those with type 1 diabetes (14 of 93 [15%] versus no or mild 24 of 471 [5%], respectively; P &lt; 0.001). Despite modern diabetes management, 39% of young adult diabetic patients developed retinopathy within the first 10 years of the disease. Nevertheless, compared with the prevalence of retinopathy (63%), after a similar duration of diabetes before the Diabetes Control and Complications Trial, this prevalence was clearly lower. Current treatment aimed to achieve strict glycemic control has reduced the risk for developing retinopathy.</description><identifier>ISSN: 0149-5992</identifier><identifier>ISSN: 1935-5548</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.26.2.349</identifier><identifier>PMID: 12547861</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Adolescent ; Adult ; Analysis ; Analysis. Health state ; Associated diseases and complications ; Biological and medical sciences ; Body Mass Index ; Clinical Medicine ; Cohort Studies ; Comparative Study ; Complications and side effects ; Demographic aspects ; Development and progression ; Diabetes ; Diabetes Mellitus ; Diabetes Mellitus, Type 1 ; Diabetes Mellitus, Type 2 ; Diabetes. Impaired glucose tolerance ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - epidemiology ; Diabetic Retinopathy - pathology ; Diabetic Retinopathy - physiopathology ; Endocrine pancreas. Apud cells (diseases) ; Endocrinology and Diabetes ; Endocrinopathies ; Endokrinologi och diabetes ; Epidemiology ; General aspects ; Glycated Hemoglobin A - analysis ; Glycosylated: analysis ; Hemoglobin A ; Human ; Humans ; Incidence ; Klinisk medicin ; Medical and Health Sciences ; Medical diagnosis ; Medical sciences ; MEDICIN ; Medicin och hälsovetenskap ; MEDICINE ; Non-U.S. Gov't ; Ophthalmology ; Prevalence ; Prevalence studies (Epidemiology) ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Retina ; Severity of Illness Index ; Support ; Sweden - epidemiology ; Time Factors ; Type I ; Type II ; Young adults</subject><ispartof>Diabetes care, 2003-02, Vol.26 (2), p.349-354</ispartof><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2003 American Diabetes Association</rights><rights>Copyright American Diabetes Association Feb 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,552,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14536616$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12547861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-24902$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-211303$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/123118$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1954420$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>HENRICSSON, Marianne</creatorcontrib><creatorcontrib>NYSTRÖM, Lennarth</creatorcontrib><creatorcontrib>ERIKSSON, Jan W</creatorcontrib><creatorcontrib>SUNDKVIST, Göran</creatorcontrib><creatorcontrib>BLOHME, Göran</creatorcontrib><creatorcontrib>ÖSTMAN, Jan</creatorcontrib><creatorcontrib>KULLBERG, Carin</creatorcontrib><creatorcontrib>SVENSSON, Maria</creatorcontrib><creatorcontrib>SCHÖLIN, Anna</creatorcontrib><creatorcontrib>ARNQVIST, Hans J</creatorcontrib><creatorcontrib>BJÖRK, Elisabeth</creatorcontrib><creatorcontrib>BOUNDER, Jan</creatorcontrib><title>The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. The Diabetes Incidence Study in Sweden (DISS) aims to register all incident cases of diabetes aged 15-34 years in Sweden. In 1987-1988, 806 cases were reported, and 627 (78%) of them were followed up with regard to retinopathy 8-10 years later. The assessment was based on retinal photographs in most cases (86%). Ten years after diagnosis, retinopathy was found in 247 patients (39%). The retinopathy was mild in 206 (33%), whereas 30 (4.8%) patients had moderate nonproliferative DR (NPDR) and 11 (1.8%) had proliferative DR (PDR). Patients with retinopathy had worse glycemic control during the years than patients without (HbA(1c) 8.1 +/- 1.5% and 6.8 +/- 1.2%, respectively; P &lt; 0.001). In a Cox regression analysis, time to retinopathy was related to high HbA(1c) (P &lt; 0.001) and high BMI (P = 0.001). Patients with type 2 diabetes had an increased prevalence of severe retinopathy (NPDR or PDR) compared with those with type 1 diabetes (14 of 93 [15%] versus no or mild 24 of 471 [5%], respectively; P &lt; 0.001). Despite modern diabetes management, 39% of young adult diabetic patients developed retinopathy within the first 10 years of the disease. Nevertheless, compared with the prevalence of retinopathy (63%), after a similar duration of diabetes before the Diabetes Control and Complications Trial, this prevalence was clearly lower. Current treatment aimed to achieve strict glycemic control has reduced the risk for developing retinopathy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Analysis</subject><subject>Analysis. Health state</subject><subject>Associated diseases and complications</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Clinical Medicine</subject><subject>Cohort Studies</subject><subject>Comparative Study</subject><subject>Complications and side effects</subject><subject>Demographic aspects</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetes Mellitus, Type 1</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - epidemiology</subject><subject>Diabetic Retinopathy - pathology</subject><subject>Diabetic Retinopathy - physiopathology</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinology and Diabetes</subject><subject>Endocrinopathies</subject><subject>Endokrinologi och diabetes</subject><subject>Epidemiology</subject><subject>General aspects</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Glycosylated: analysis</subject><subject>Hemoglobin A</subject><subject>Human</subject><subject>Humans</subject><subject>Incidence</subject><subject>Klinisk medicin</subject><subject>Medical and Health Sciences</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>MEDICIN</subject><subject>Medicin och hälsovetenskap</subject><subject>MEDICINE</subject><subject>Non-U.S. Gov't</subject><subject>Ophthalmology</subject><subject>Prevalence</subject><subject>Prevalence studies (Epidemiology)</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Retina</subject><subject>Severity of Illness Index</subject><subject>Support</subject><subject>Sweden - epidemiology</subject><subject>Time Factors</subject><subject>Type I</subject><subject>Type II</subject><subject>Young adults</subject><issn>0149-5992</issn><issn>1935-5548</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>D8T</sourceid><recordid>eNqNkl1rFDEUhgdRbK3eeyVBUBScNckkk8llaf0oFLzY6m04kznZps5OpskMy_4rf6Kp3booFiSEJCfPe95zSIriOaMLXlXqfefBQsQFrxd8UQn9oDhkupKllKJ5WBxSJnQpteYHxZOUriilQjTN4-KAcSlUU7PD4sfFJZKzwfoOB4skOBJx8kMYYbrcEkbJFiEmAm7CSLLdagjJJ-IHsg3zsCLQzf1ERgxjj2Tjp0ty6qHFCVNOlPJdIi6GNZmyzQCTD8MmW5ExjHP_61i2kLDbq_a1LKe52944LTeYI-TN6dly-fZp8chBn_DZbj0qvn78cHHyuTz_8uns5Pi8XMm6mUqV25ONU7KqWmGhFh3w1klrqeVO0VYyboEiq5ErpmnHQUNXK6qxUdZ1UB0V5W3etMFxbs0Y_Rri1gTwZhf6nndopGas0ZlX9_JjDN1edCdkWgrBaVae36vs5zHPNs8bBVLtai2ckciUEYyBaRw0ptW6zkWIjkmb0727N92p_3ZsQlyZeTacsYpW_4f3PvNCU57x17d47ul6xjSZtU8W-x4GDHMyimsllZAZfPkXeBXmOOQnM5xTVgvO1d58BT0aP7gwRbArHDBCHwZ0PoePdUMrroXav8kfeB4drr39F_9iV8PcrrH73dvd98_Aqx0AyULvIuTfl_Zc7qOuWV39BFErGDQ</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>HENRICSSON, Marianne</creator><creator>NYSTRÖM, Lennarth</creator><creator>ERIKSSON, Jan W</creator><creator>SUNDKVIST, Göran</creator><creator>BLOHME, Göran</creator><creator>ÖSTMAN, Jan</creator><creator>KULLBERG, Carin</creator><creator>SVENSSON, Maria</creator><creator>SCHÖLIN, Anna</creator><creator>ARNQVIST, Hans J</creator><creator>BJÖRK, Elisabeth</creator><creator>BOUNDER, Jan</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DG8</scope><scope>DF2</scope><scope>AGCHP</scope><scope>D8T</scope><scope>D95</scope><scope>ZZAVC</scope></search><sort><creationdate>20030201</creationdate><title>The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)</title><author>HENRICSSON, Marianne ; NYSTRÖM, Lennarth ; ERIKSSON, Jan W ; SUNDKVIST, Göran ; BLOHME, Göran ; ÖSTMAN, Jan ; KULLBERG, Carin ; SVENSSON, Maria ; SCHÖLIN, Anna ; ARNQVIST, Hans J ; BJÖRK, Elisabeth ; BOUNDER, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g568t-778658f7533b4ca64da2bf5cc0c2f70b512ca0e16e27190d2a9ad6709e87cfda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Analysis</topic><topic>Analysis. Health state</topic><topic>Associated diseases and complications</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Clinical Medicine</topic><topic>Cohort Studies</topic><topic>Comparative Study</topic><topic>Complications and side effects</topic><topic>Demographic aspects</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetes Mellitus, Type 1</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - epidemiology</topic><topic>Diabetic Retinopathy - pathology</topic><topic>Diabetic Retinopathy - physiopathology</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinology and Diabetes</topic><topic>Endocrinopathies</topic><topic>Endokrinologi och diabetes</topic><topic>Epidemiology</topic><topic>General aspects</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Glycosylated: analysis</topic><topic>Hemoglobin A</topic><topic>Human</topic><topic>Humans</topic><topic>Incidence</topic><topic>Klinisk medicin</topic><topic>Medical and Health Sciences</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>MEDICIN</topic><topic>Medicin och hälsovetenskap</topic><topic>MEDICINE</topic><topic>Non-U.S. Gov't</topic><topic>Ophthalmology</topic><topic>Prevalence</topic><topic>Prevalence studies (Epidemiology)</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Retina</topic><topic>Severity of Illness Index</topic><topic>Support</topic><topic>Sweden - epidemiology</topic><topic>Time Factors</topic><topic>Type I</topic><topic>Type II</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HENRICSSON, Marianne</creatorcontrib><creatorcontrib>NYSTRÖM, Lennarth</creatorcontrib><creatorcontrib>ERIKSSON, Jan W</creatorcontrib><creatorcontrib>SUNDKVIST, Göran</creatorcontrib><creatorcontrib>BLOHME, Göran</creatorcontrib><creatorcontrib>ÖSTMAN, Jan</creatorcontrib><creatorcontrib>KULLBERG, Carin</creatorcontrib><creatorcontrib>SVENSSON, Maria</creatorcontrib><creatorcontrib>SCHÖLIN, Anna</creatorcontrib><creatorcontrib>ARNQVIST, Hans J</creatorcontrib><creatorcontrib>BJÖRK, Elisabeth</creatorcontrib><creatorcontrib>BOUNDER, Jan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Linköpings universitet</collection><collection>SWEPUB Uppsala universitet</collection><collection>SWEPUB Lunds universitet full text</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Lunds universitet</collection><collection>SwePub Articles full text</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HENRICSSON, Marianne</au><au>NYSTRÖM, Lennarth</au><au>ERIKSSON, Jan W</au><au>SUNDKVIST, Göran</au><au>BLOHME, Göran</au><au>ÖSTMAN, Jan</au><au>KULLBERG, Carin</au><au>SVENSSON, Maria</au><au>SCHÖLIN, Anna</au><au>ARNQVIST, Hans J</au><au>BJÖRK, Elisabeth</au><au>BOUNDER, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>26</volume><issue>2</issue><spage>349</spage><epage>354</epage><pages>349-354</pages><issn>0149-5992</issn><issn>1935-5548</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>To estimate the prevalence and severity of diabetic retinopathy (DR) 10 years after diagnosis in a nationwide population-based cohort study of young adult diabetic patients in Sweden. The Diabetes Incidence Study in Sweden (DISS) aims to register all incident cases of diabetes aged 15-34 years in Sweden. In 1987-1988, 806 cases were reported, and 627 (78%) of them were followed up with regard to retinopathy 8-10 years later. The assessment was based on retinal photographs in most cases (86%). Ten years after diagnosis, retinopathy was found in 247 patients (39%). The retinopathy was mild in 206 (33%), whereas 30 (4.8%) patients had moderate nonproliferative DR (NPDR) and 11 (1.8%) had proliferative DR (PDR). Patients with retinopathy had worse glycemic control during the years than patients without (HbA(1c) 8.1 +/- 1.5% and 6.8 +/- 1.2%, respectively; P &lt; 0.001). In a Cox regression analysis, time to retinopathy was related to high HbA(1c) (P &lt; 0.001) and high BMI (P = 0.001). Patients with type 2 diabetes had an increased prevalence of severe retinopathy (NPDR or PDR) compared with those with type 1 diabetes (14 of 93 [15%] versus no or mild 24 of 471 [5%], respectively; P &lt; 0.001). Despite modern diabetes management, 39% of young adult diabetic patients developed retinopathy within the first 10 years of the disease. Nevertheless, compared with the prevalence of retinopathy (63%), after a similar duration of diabetes before the Diabetes Control and Complications Trial, this prevalence was clearly lower. Current treatment aimed to achieve strict glycemic control has reduced the risk for developing retinopathy.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12547861</pmid><doi>10.2337/diacare.26.2.349</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2003-02, Vol.26 (2), p.349-354
issn 0149-5992
1935-5548
1935-5548
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_591189
source MEDLINE; SWEPUB Freely available online; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Analysis
Analysis. Health state
Associated diseases and complications
Biological and medical sciences
Body Mass Index
Clinical Medicine
Cohort Studies
Comparative Study
Complications and side effects
Demographic aspects
Development and progression
Diabetes
Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetes. Impaired glucose tolerance
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - epidemiology
Diabetic Retinopathy - pathology
Diabetic Retinopathy - physiopathology
Endocrine pancreas. Apud cells (diseases)
Endocrinology and Diabetes
Endocrinopathies
Endokrinologi och diabetes
Epidemiology
General aspects
Glycated Hemoglobin A - analysis
Glycosylated: analysis
Hemoglobin A
Human
Humans
Incidence
Klinisk medicin
Medical and Health Sciences
Medical diagnosis
Medical sciences
MEDICIN
Medicin och hälsovetenskap
MEDICINE
Non-U.S. Gov't
Ophthalmology
Prevalence
Prevalence studies (Epidemiology)
Public health. Hygiene
Public health. Hygiene-occupational medicine
Retina
Severity of Illness Index
Support
Sweden - epidemiology
Time Factors
Type I
Type II
Young adults
title The Incidence of retinopathy 10 years after diagnosis in young adult people with Diabetes results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A25%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Incidence%20of%20retinopathy%2010%20years%20after%20diagnosis%20in%20young%20adult%20people%20with%20Diabetes%20results%20from%20the%20nationwide%20population-based%20Diabetes%20Incidence%20Study%20in%20Sweden%20(DISS)&rft.jtitle=Diabetes%20care&rft.au=HENRICSSON,%20Marianne&rft.date=2003-02-01&rft.volume=26&rft.issue=2&rft.spage=349&rft.epage=354&rft.pages=349-354&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.26.2.349&rft_dat=%3Cgale_swepu%3EA98032947%3C/gale_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220164227&rft_id=info:pmid/12547861&rft_galeid=A98032947&rfr_iscdi=true